MGMT and central nervous system cancer: EV DNA show tissue‐specific and ultrasensitive results compared to cell‐free DNA in acquired resistance patients, revealing that EV DNA may provide a more accurate, cheaper, and faster diagnostic result.[229] Oldrini et al. suggest that MGMT genomic arrangement and TMZ resistance simultaneously occur in some recurrent glioma patients.